iFR
iFR
iFR

Earlier this year, the Barnes-Jewish Hospital at Washington University School of Medicine in St. Louis adopted the instant wave-Free Ratio (iFR) technology. The iFR modality is a pressure-derived hyperemia-free index for assessment of coronary stenosis relevance. 

The U.S. Food and Drug Administration has allowed marketing of the NephroCheck test, a first-of-a-kind laboratory test to help determine if certain critically ill hospitalized patients are at risk of developing moderate to severe acute kidney injury (AKI) in the 12 hours following the administration of the test.

Coquí RadioPharmaceuticals Corp. is working to become the first commercial producer of lifesaving medical isotopes in the United States. 


September 29, 2014 — Before undergoing cardiac imaging procedures involving radiation, healthcare providers should help patients understand why the procedure is needed and its potential benefits and risks, including risks related to radiation exposure, according to a new scientific statement in the American Heart Association's (AHA) journal Circulation.

September 29, 2014 — AliveCor announced the launch of the latest version of the AliveECG app, which provides patients with free real-time atrial fibrillation (AF) detection in electrocardiogram (ECG) recordings using its new U.S. Food and Drug Administration (FDA)-cleared algorithm.

Claron Technology introduces support for the BlackBerry Passport for its Nil family of zero-footprint enterprise medical imaging viewers, which enable anytime, anywhere web-based review of a full range of imaging modalities and related data. 

Transcatheter Technologies GmbH has announced that results of a first-in-human clinical study of its TRINITY system have been published ahead of print publication in the July issue of the peer-reviewed medical journal EuroIntervention. 

Thoratec Corporation announced that it has begun to enroll patients in the HeartMate III U.S. clinical trial. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now